
1. Biomedicines. 2021 Nov 5;9(11). pii: 1627. doi: 10.3390/biomedicines9111627.

Different HCV Exposure Drives Specific miRNA Profile in PBMCs of HIV Patients.

Valle-Millares D(1), Brochado-Kith Ó(1), Martín-Carbonero L(2),
Domínguez-Domínguez L(3), Ryan P(4), De Los Santos I(5), De la Fuente S(6),
Castro JM(2), Lagarde M(3), Cuevas G(4), Mayoral-Muñoz M(2), Matarranz M(3), Díez
V(4), Gómez-Sanz A(1), Martínez-Román P(1), Crespo-Bermejo C(7), Palladino C(8), 
Muñoz-Muñoz M(9), Jiménez-Sousa MA(1), Resino S(1), Briz V(7),
Fernández-Rodríguez A(1)(10), On Behalf Of Multidisciplinary Group Of Viral
Coinfection Hiv/Hepatitis Covihep.

Author information: 
(1)Unit of Viral Infection and Immunity, National Center for Microbiology,
Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain.
(2)Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain.
(3)VIH Servicio de Medicina Interna Research Institute Hospital 12 de Octubre
(i+12), 28041 Madrid, Spain.
(4)Department of Infectious Diseases, Infanta Leonor Teaching Hospital, 28031
Madrid, Spain.
(5)Internal Medicine Servicie Hospital Universitario de La Princesa, 28006
Madrid, Spain.
(6)Internal Medicine Service Hospital Puerta de Hierro, 28222 Madrid, Spain.
(7)Laboratory of Reference and Research on Viral Hepatitis, National Center for
Microbiology, Institute of Health Carlos III, 28220 Majadahonda, Madrid, Spain.
(8)Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy,
Universidade de Lisboa, 1649-003 Lisbon, Portugal.
(9)Department of Animal Genetics, Instituto Nacional de Investigación y
Alimentación Agraria y Alimentaria (INIA), 28040 Madrid, Spain.
(10)Faculty of Medicine, Universidad Alfonso X el Sabio, Avenida Universidad 1,
28691 Villanueva de la Cañada, Madrid, Spain.

Micro RNAs (miRNAs) are essential players in HIV and HCV infections, as both
viruses modulate cellular miRNAs and interact with the miRNA-mediated host
response. We aim to analyze the miRNA profile of HIV patients with different
exposure to HCV to explore specific signatures in the miRNA profile of PBMCs for 
each type of infection. We massively sequenced small RNAs of PBMCs from 117 HIV+ 
infected patients: 45 HIV+ patients chronically infected with HCV (HIV/HCV+), 36 
HIV+ that spontaneously clarified HCV after acute infection (HIV/HCV-) and 36
HIV+ patients without previous HCV infection (HIV). Thirty-two healthy patients
were used as healthy controls (HC). Differential expression analysis showed
significantly differentially expressed (SDE) miRNAs in HIV/HCV+ (n = 153),
HIV/HCV- (n = 169) and HIV (n = 153) patients. We found putative dysregulated
pathways, such as infectious-related and PI3K signaling pathways, common in all
contrasts. Specifically, putatively targeted genes involved in antifolate
resistance (HIV/HV+), cancer-related pathways (HIV/HCV-) and HIF-signaling (HIV) 
were identified, among others. Our findings revealed that HCV strongly influences
the expression profile of PBMCs from HIV patients through the disruption of its
miRNome. Thus, different HCV exposure can be identified by specific miRNA
signatures in PBMCs.

DOI: 10.3390/biomedicines9111627 
PMCID: PMC8615810
PMID: 34829855 

